Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.02%
#3 Fabric Protocol Fabric Protocol +30.68%
#4 Nockchain Nockchain +19.84%
#5 Cysic Cysic +19.17%
#6 Bedrock Bedrock +18.72%
#7 Perle Perle +11.77%
#8 The Black Bull The Black Bull +10.40%
#9 FOLKS FOLKS +7.85%
#10 Epic Chain Epic Chain +7.11%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
CanadaBis Capital Inc. CanadaBis Capital Inc.

CanadaBis Capital Inc.

CANB
Rank in Stocks #37677
CanadaBis Capital Inc. is a Canadian firm specializing in the production and... CanadaBis Capital Inc. is a Canadian firm specializing in the production and distribution of recreational cannabis and its extracted forms. The organization's business activities are divided into three principal divisions: Cultivation and Wholesale, Retail, and Extraction and Tolling. Its Cultivation and Wholesale segment is dedicated to growing and supplying cannabis and related goods, channeling them through provincial liquor and cannabis regulatory boards. The Retail division focuses on direct-to-consumer sales of cannabis and complementary products from locations owned and managed by the company. Furthermore, the Extraction and Tolling segment provides specialized cannabinoid extraction services to other licensed producers in the industry. The corporate headquarters for CanadaBis Capital Inc. are situated in Red Deer, Canada.
Share Price
$0.01100905
Last synced: 2026-05-07
Market Cap
$1.52M
Change (1 day)
0.00%
Change (1 year)
-66.19%
Country
CA
Trade CanadaBis Capital Inc. (CANB)

Category

Healthcare
P/E ratio for CanadaBis Capital Inc. (CANB)
P/E ratio as of 2026 TTM: 0
According to CanadaBis Capital Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for CanadaBis Capital Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 41.61 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.